HISTORY, About the CIPLA , How The pharmaceutical works CIPLA Products ,SWOT ANALYSIS ,Synergy Opportunities

1. “ A Study on CIPLA ”
A
PRESENTATION ON “ CIPLA ”
SUBJECT: BUSINESS RESEARCH METHODS
Submitted By ; Mr. GHANI NAIK
Mcom – 2sem
AICM,
Submitted To ; Dr. HARISH MBA Mcom M Phil P hD.
Assistant Professor
AICM
2019 – 2020

2. “ A Study on CIPLA ”
Contents
S.no Particulars
1. HISTORY
2. About the CIPLA
3. How The pharmaceutical works
4. CIPLA Products
5. SWOT ANALYSIS
6. Synergy Opportunities

3. “ A Study on CIPLA ”
HISTORY
Cipla Limited is an Indian multinational pharmaceutical and biotechnology
company, headquartered in Mumbai, India. Cipla primarily develops
medicines to treat respiratory, cardiovascular disease, arthritis, diabetes,
weight control and depression; other medical conditions.
As of 17 September 2014, its market capitalisation ₹was 49,611.58 crore
₹(equivalent to 530 billion or US$7.5 billion in 2019), making it India's 42nd
largest publicly traded company by market value.
On 23 April 2019, Cipla appointed Dr. Raju Mistry as Global Chief People
Officer.
About CIPLA LIMITED
Cipla is a market-leading medicine maker in India. The company has roughly 1,500
pharmaceutical products in more than 60 therapeutic categories. Some are sold
domestically, while the rest reach international markets in more than 150 countries. It
offers prescription drugs for all kinds of ailments -- arthritis, cancer, depression -- as
well as over-the-counter drugs for colds, oral hygiene, and skin care. Cipla leads the
domestic retail pharmaceutical market. The firm also makes bulk drugs, agrochemicals,
and animal products. It has eight manufacturing plants located throughout the country.
Cipla was founded as The Chemical, Industrial, & Pharmaceutical Laboratories by
Khwaja Abdul Hamied in 1935.

4. “ A Study on CIPLA ”
Cipla Limited

5. “ A Study on CIPLA ”

6. “ A Study on CIPLA ”

7. “ A Study on CIPLA ”
SWOT ANALYSIS

8. “ A Study on CIPLA ”

9. “ A Study on CIPLA ”
THANK YOU